These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15688901)

  • 21. Self-control of psychophysiologic response to motion stress: using biofeedback to treat airsickness.
    Jones DR; Levy RA; Gardner L; Marsh RW; Patterson JC
    Aviat Space Environ Med; 1985 Dec; 56(12):1152-7. PubMed ID: 3910020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing motion sickness: a comparison of autogenic-feedback training and an alternative cognitive task.
    Toscano WB; Cowings PS
    Aviat Space Environ Med; 1982 May; 53(5):449-53. PubMed ID: 7092752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantitative evaluation of the clinical manifestations of motion sickness].
    Galle RR
    Kosm Biol Aviakosm Med; 1981; 15(3):72-5. PubMed ID: 7289550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing success or failure in the AH-64 course.
    Cornum RL; Caldwell JL; Ludwick R
    Aviat Space Environ Med; 1993 Dec; 64(12):1120-4. PubMed ID: 8291992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of airsickness among military parachutists.
    Antuñano MJ; Hernandez JM
    Aviat Space Environ Med; 1989 Aug; 60(8):792-7. PubMed ID: 2775137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motion sickness in USAF flying personnel.
    Ryback RS; Rudd RE; Matz GJ; Jennings CL
    Aerosp Med; 1970 Jun; 41(6):672-7. PubMed ID: 4392836
    [No Abstract]   [Full Text] [Related]  

  • 27. The development of an evidence-based physical self-management rehabilitation programme for cancer survivors.
    van Weert E; Hoekstra-Weebers JE; May AM; Korstjens I; Ros WJ; van der Schans CP
    Patient Educ Couns; 2008 May; 71(2):169-90. PubMed ID: 18255249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenytoin as a countermeasure for motion sickness in NASA maritime operations.
    Woodard D; Knox G; Myers KJ; Chelen W; Ferguson B
    Aviat Space Environ Med; 1993 May; 64(5):363-6. PubMed ID: 8503807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motion sickness questionnaire and field independence scores as predictors of success in naval aviation training.
    Kennedy RS
    Aviat Space Environ Med; 1975 Nov; 46(11):1349-52. PubMed ID: 1212138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flight psychology at Sheppard Air Force Base.
    King RE; Lochridge GK
    Aviat Space Environ Med; 1991 Dec; 62(12):1185-8. PubMed ID: 1755802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of physical training after myocardial infarction and its effect on return to work, morbidity and mortality.
    Palatsi I
    Acta Med Scand Suppl; 1976; 599():7-84. PubMed ID: 16981325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of histaminergic drugs in experimental motion sickness.
    Matsnev EI; Sigaleva EE
    J Vestib Res; 2007; 17(5-6):313-21. PubMed ID: 18626141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programma 2000: celebrating 10 years of activity of an Italian pilot programme on early intervention in psychosis.
    Cocchi A; Meneghelli A; Preti A
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1003-12. PubMed ID: 19016088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The preventive and treatment tours as a part of psychological aid system provided for soldiers who participated in the military missions abroad].
    Tomaszewska I
    Pol Merkur Lekarski; 2008; 25 Suppl 1():29-34. PubMed ID: 19025046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motion-sickness medications for aircrew: impact on psychomotor performance.
    Paul MA; MacLellan M; Gray G
    Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperventilation in a motion sickness desensitization program.
    Mert A; Bles W; Nooij SA
    Aviat Space Environ Med; 2007 May; 78(5):505-9. PubMed ID: 17539445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose ondansetron for reducing motion sickness in highly susceptible subjects.
    Muth ER; Elkins AN
    Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gains and losses of structured information collection in the evaluation of 'rehabilitation in the community' programmes: ten lessons learnt during actual evaluations.
    Velema JP; Finkenflügel HJ; Cornielje H
    Disabil Rehabil; 2008; 30(5):396-404. PubMed ID: 17852313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.